HealthLynked Corp (HLYK)
HLYK is quoted over the counter, not listed on an exchange. HealthLynked Corp files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | HLYK, quoted over the counter |
| SEC CIK | 0001680139 |
| OTC Markets tier | OTCQB (price source, 2026-11-13) |
| SEC industry code | Services-Offices & Clinics of Doctors of Medicine |
| Business address | Naples, FL |
| Incorporated in | NV |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Without raising additional capital, there is substantial doubt about the Company's ability to continue as a going concern through August 14, 2027." | 10-Q 2026-08-14 |
| Cash and burn | $13K cash; operating cash flow -$359K a quarter. | Report 2026-06-30 |
| Shares outstanding | 2,953,225 (2026-08-14); 281,947,151 a year earlier; 265,559,110 three years earlier. 1y figure adjusted for split (1-for-100 overall); 3y figure adjusted for split (1-for-100 overall). | Cover page 2026-08-14 |
| Reverse splits, 3 years | 1; latest 1-for-100 on 2025-09-04 | Source 2025-09-04 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | RBSM LLP, HOUSTON, Texas, United States | PCAOB Form AP 2026-03-31 |
| Late filings, 12 months | 1 NT notice | NT 10-Q 2025-11-17 |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $250K | -$820K | -$350K | $13K | $7.1M | $1.4M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $423K | -$1.6M | -$222K | $24K | $6.9M | $1.7M | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | $310K | -$676K | -$419K | $37K | $4.6M | $2.1M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $389K | -$852K | -$444K | $11K | $294K | $2.4M | 10-Q 2025-11-19 |
| Q2 2025 2025-06-30 | $592K | -$701K | -$418K | $20K | $292K | $2.6M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $774K | -$1.1M | -$433K | $22K | $329K | $2.8M | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $619K | -$1.2M | -$744K | $76K | $127K | $3.0M | 10-K 2025-03-31 |
| Q3 2024 2024-09-30 | $590K | -$2.0M | -$1.0M | $15K | $199K | $3.3M | 10-Q 2024-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1/A | 2026-05-29 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-07-16 |
Source: SEC EDGAR submissions feed, 225 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier